This is in keeping with previous studies reporting the existence of subclonal heterogeneity within the clonotypic CLL BcR IG gene rearrangements likely in the context of ongoing antigen interactions (31–33). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.